Synergy CHC Corp. income statement SNYRQ

Annual Quarterly

In fiscal 2025, which ended Dec 31, 2025, Synergy CHC Corp. reported revenue of $30.4 million, down 12.8% from the year before. It recorded a net loss of $12.3 million. The operating loss came to $8.5 million, an operating margin of -27.8%. Diluted earnings per share were -$1.27. Over the twelve months ended Mar 31, 2026, revenue was $27.7 million and the net loss was $15.8 million. Across the 8 fiscal years shown, revenue grew from $9,158 in fiscal 2014 to $30.4 million in fiscal 2025, about 218.4% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line	FY 2026 Mar 31, 2026	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2019 Dec 31, 2019	FY 2018 Dec 31, 2018	FY 2017 Dec 31, 2017	FY 2016 Dec 31, 2016	FY 2015 Dec 31, 2015	FY 2014 Dec 31, 2014	FY 2012 Jul 31, 2013
Revenue	28	30 -12.8%	35	29 -13.2%	34 -5.0%	36 +2.2%	35 +158.9%	13 +146835.8%	0	—
Cost of revenue	10	10 -9.9%	11	9 -17.2%	11 +12.4%	10 -3.8%	10 +92.3%	5 +94418.0%	0	—
Gross profit	18	20 -14.1%	24	20 -11.3%	23 -11.6%	26 +4.6%	25 +202.3%	8 +229946.5%	0	—
Selling, general and administrative	22	22 +24.1%	18	17 -31.8%	25 +10.8%	22 +22.4%	18 +160.2%	7 +633.6%	1	0
Operating income	-11	-8 -245.8%	6	-8 -61.8%	-5 -369.9%	2 -37.9%	3 +503.6%	0	—	—
Interest income	0	0 +889.2%	0	—	—	—	—	—	—	—
Foreign currency gain (loss)	-0	-0 +89.8%	-0	0 +101.0%	-0 -359.5%	0 +276.4%	0 +124.7%	-0	—	—
Other income (expense)	-5	-4 -5.3%	-4	1	—	—	—	—	—	—
Pretax income	-16	-12 -648.9%	2	-9 -41.6%	-6 -885.7%	1 +450.3%	0 +102.1%	-7	—	—
Income tax	0	0 +15.1%	0	-0 -153.1%	0 -21.6%	0 -66.5%	1 +142.2%	0	0	—
Net income	-16	-12 -680.8%	2	-9 -49.5%	-6 -1333.2%	0 +162.7%	-1 +89.4%	-8 -685.0%	-1	-0
Basic EPS	-1.52	-1.27 -553.6%	0.28	-0.10 -42.9%	-0.07	—	—	—	—	—
Diluted EPS	-1.52	-1.27 -553.6%	0.28	-0.10 -42.9%	-0.07	—	—	—	—	—
Weighted average shares, basic	10	10 +28.1%	8	90 +0.0%	90	—	—	—	—	—
Weighted average shares, diluted	10	10 +27.4%	8	—	90	—	—	—	—	5
Other measures
Depreciation and amortization	0	0 +0.0%	0	1 -33.5%	2 +22.0%	1 +27.5%	1 +92.6%	1	—	—
EBITDA	-11	-8 -240.3%	6	-7 -117.9%	-3 -193.4%	3 -19.2%	4 +275.2%	1	—	—
Interest coverage	-1.61x	-1.43x	1.41x	—	—	—	—	—	—	—
Margins
Gross margin	65.37%	66.83%	67.87%	68.87%	67.37%	72.42%	70.71%	60.55%	38.68%	—
Operating margin	-39.61%	-27.84%	16.65%	-27.10%	-14.54%	5.12%	8.42%	3.61%	—	—
Pretax margin	-56.57%	-40.24%	6.39%	-30.92%	-18.95%	2.29%	0.43%	-53.11%	—	—
Profit margin	-56.98%	-40.62%	6.10%	-31.36%	-18.21%	1.40%	-2.29%	-56.01%	-10,483.64%	—
EBITDA margin	-39.13%	-27.40%	17.04%	-22.97%	-9.15%	9.31%	11.78%	8.13%	—	—
Effective tax rate	—	—	4.58%	—	—	38.75%	637.23%	—	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as: SNYRQ (OTC)
Fiscal year ends: December 31
Incorporated in: NV
Headquarters: Westbrook, ME
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1562733
Former names: Synergy Strips Corp. (until Aug 6, 2015); Oro Capital Corporation, Inc. (until Apr 24, 2014)

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.